BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 330 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2022. The put-call ratio across all filers is 0.46 and the average weighting 1.1%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $68,605,000 | +10232.1% | 466,377 | +9865.3% | 0.28% | +28000.0% |
| Q2 2022 | $664,000 | -92.9% | 4,680 | -94.2% | 0.00% | -96.4% |
| Q1 2022 | $9,389,000 | -58.2% | 80,400 | -51.8% | 0.03% | -50.9% |
| Q4 2021 | $22,467,000 | +1396.8% | 166,801 | +853.1% | 0.06% | +1800.0% |
| Q4 2020 | $1,501,000 | +451.8% | 17,500 | +250.0% | 0.00% | +200.0% |
| Q4 2019 | $272,000 | +31.4% | 5,000 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $207,000 | -76.0% | 5,000 | -75.0% | 0.00% | -50.0% |
| Q2 2019 | $864,000 | – | 20,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 490,422 | $12,755,876 | 13.24% |
| FNY Investment Advisers, LLC | 30 | $0 | 0.00% |